Asik, E. Et Al. 2019. EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer. NANOMEDICINE , vol.14, no.17 , 2315-2338.

Asik, E., Akpinar, Y., Caner, A., Kahraman, N., GÜRAY, N. T., Volkan, M., ... Albarracins, C.(2019). EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer. NANOMEDICINE , vol.14, no.17, 2315-2338.

Asik, Elif Et Al. "EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer," NANOMEDICINE , vol.14, no.17, 2315-2338, 2019

Asik, Elif Et Al. "EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer." NANOMEDICINE , vol.14, no.17, pp.2315-2338, 2019

Asik, E. Et Al. (2019) . "EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer." NANOMEDICINE , vol.14, no.17, pp.2315-2338.

@article{article, author={Elif Asik Et Al. }, title={EF2-kinase targeted cobalt-ferrite siRNA-nanotherapy suppresses BRCA1-mutated breast cancer}, journal={NANOMEDICINE}, year=2019, pages={2315-2338} }